HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Eastern Europe and Central Asia  /  ARM

Armenia

Armenia's National Centre for Infectious Diseases (NCID) publishes an HIV situation analysis. Our project reads the HIV cases registered in every year from 2015 to 2025, among citizens of Armenia and among foreign citizens, from the 2025 situation analysis. The 2025 report enters the panel only where the yearly counts agree with the totals printed in the text of the report, and where two charts of the citizen counts agree in every shared year.

7,800
People living with HIV, 2025
WHO Global Health Observatory
55.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$6k
United States HIV disbursements, 2014
OECD Creditor Reporting System
$2.5m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$2.5m$5m$7.5m20022005200820112014201720202023$2.5m$6k$2.4m$7k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $160k — — —
2003 $1.6m $135k $1.3m $135k
2004 $1.3m $436k $506k $435k
2005 $3.1m $71k $2.6m $80k
2006 $2.7m $105k $850k $51k
2007 $2.4m $72k $1.2m $126k
2008 $2.6m — $1.8m —
2009 $5.2m — $4.5m —
2010 $2.4m — $2.0m —
2011 $4.6m — $4.3m —
2012 $4.6m — $4.1m —
2013 $3.8m — $3.7m —
2014 $3.4m $6k $3.4m $7k
2015 $1.0m — $1.0m —
2016 $2.0m — $2.0m —
2017 $1.4m — $1.4m —
2018 $1.8m — $1.8m —
2019 $899k — $876k —
2020 $3.7m — $3.7m —
2021 $7.7m — $7.7m —
2022 $4.2m — $4.2m —
2023 $5.5m — $5.4m —
2024 $2.5m — $2.4m —

23 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
05k10k2000200320062009201220152018202120247,3003,800
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 200 0 500 —
2001 200 0 500 —
2002 500 0 500 —
2003 500 0 520 —
2004 500 0 680 —
2005 590 0 870 —
2006 770 530 1,100 —
2007 980 690 1,400 —
2008 1,200 870 1,700 —
2009 1,500 1,100 2,000 —
2010 1,800 1,300 2,300 500
2011 2,100 1,600 2,700 500
2012 2,400 1,900 3,000 500
2013 2,800 2,300 3,400 570
2014 3,100 2,600 3,800 730
2015 3,500 3,000 4,100 930
2016 3,900 3,300 4,600 1,200
2017 4,300 3,600 5,000 1,500
2018 4,700 4,000 5,500 1,900
2019 5,100 4,300 6,100 2,200
2020 5,500 4,600 6,600 2,300
2021 5,900 4,800 7,200 2,600
2022 6,400 5,100 8,000 3,100
2023 7,000 5,500 9,200 3,400
2024 7,300 5,700 10,000 3,800

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%20%40%60%2010201220142016201820202022202465.0%52.0%45.0%
  • Diagnosed
  • On treatment
  • Virally suppressed
YearDiagnosedOn treatmentVirally suppressed
2010 40.0% 14.0% —
2011 41.0% 15.0% —
2012 43.0% 18.0% —
2013 44.0% 21.0% 18.0%
2014 48.0% 23.0% 20.0%
2015 49.0% 27.0% 20.0%
2016 50.0% 30.0% 21.0%
2017 52.0% 36.0% 30.0%
2018 54.0% 40.0% 34.0%
2019 57.0% 43.0% 38.0%
2020 58.0% 42.0% 35.0%
2021 60.0% 45.0% 32.0%
2022 62.0% 49.0% 34.0%
2023 62.0% 49.0% 42.0%
2024 65.0% 52.0% 45.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Armenia

3,214 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 821 29 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 271 12 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 140 17 2000–2025 extranet.who.int 2026-10-16
Demographic and Health Surveys Survey 124 3 2000–2016 api.dhsprogram.com 2026-10-16
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 94 16 2016–2024 hivfinancial.unaids.org 2026-10-12
Global Fund Data Service Programme record 84 7 2017–2025 fetch.theglobalfund.org 2026-10-12
WHO Global Health Expenditure Database Expenditure account 70 7 2014–2023 apps.who.int 2026-10-12
OECD Creditor Reporting System Expenditure account 51 3 2002–2024 sdmx.oecd.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
IATI, through d-portal Expenditure account 48 3 2001–2026 d-portal.org 2026-10-12
WHO HIV testing services dashboard Programme record 42 3 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
UNAIDS Data 2025 country databook Expenditure account 15 3 2016–2023 aidsinfo.unaids.org 2026-10-15
ForeignAssistance.gov Expenditure account 13 3 2003–2014 foreignassistance.gov 2026-10-29
National Centre for Infectious Diseases of Armenia, HIV situation analysis 2025 Programme record 11 1 2015–2025 ncid.am 2026-10-21
Global Fund allocations Expenditure account 3 1 2017–2023 fetch.theglobalfund.org 2026-10-12

Indicators held

82 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 3 2017–2019 WHO Global Tuberculosis Programme $17k (2019)
Budget required for collaborative TB/HIV activities Financing USD 4 2018–2025 WHO Global Tuberculosis Programme $150k (2025)
Country-reported HIV expenditure, all sources Financing USD 19 2012–2024 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $5.3m (2024)
Domestic funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $2.0m (2024)
Domestic public HIV expenditure Financing USD 15 2016–2024 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $2.7m (2024)
Expected Global Fund funding for the national TB programme Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $1.1m (2025)
Expected USAID funding for the national TB programme Financing USD 2 2018–2019 WHO Global Tuberculosis Programme $0 (2019)
Expected domestic funding for the national TB programme Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $3.0m (2025)
Expected funding for collaborative TB/HIV activities Financing USD 4 2018–2025 WHO Global Tuberculosis Programme $150k (2025)
External HIV and STD spending, national health accounts Financing USD 10 2014–2023 WHO Global Health Expenditure Database $2.1m (2023)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $2.5m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 12 2001–2016 IATI, through d-portal $0 (2016)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 12 2015–2026 IATI, through d-portal $299k (2026)
External HIV financing from the United States (ODA) Financing USD 12 2003–2014 ForeignAssistance.gov, OECD Creditor Reporting System $6k (2014)
Funding received for collaborative TB/HIV activities Financing USD 3 2017–2019 WHO Global Tuberculosis Programme $17k (2019)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 3 2017–2023 Global Fund allocations 6,550,471 (2023)
Global Fund HIV disbursements to the country Financing USD 54 2003–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $2.4m (2026)
Global Fund funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $964k (2024)
Government HIV and STD spending as a share of government health spending Financing percent 10 2014–2023 WHO Global Health Expenditure Database 0.5% (2023)
Government HIV and STD spending, national health accounts Financing USD 10 2014–2023 WHO Global Health Expenditure Database $1.8m (2023)
HIV and STD spending as a share of all external health spending Financing percent 10 2014–2023 WHO Global Health Expenditure Database 23.9% (2023)
HIV and STD spending as a share of all health spending Financing percent 10 2014–2023 WHO Global Health Expenditure Database 0.2% (2023)
HIV and STD spending, national health accounts Financing USD 10 2014–2023 WHO Global Health Expenditure Database $5.6m (2023)
HIV spending on TB/HIV co-infection Financing USD 6 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $13k (2024)
HIV spending on community mobilisation and system strengthening Financing USD 4 2016–2023 UNAIDS Global AIDS Monitoring expenditure database $27k (2023)
HIV spending on critical enablers Financing USD 7 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $81k (2024)
HIV spending on gender programmes Financing USD 3 2016–2022 UNAIDS Global AIDS Monitoring expenditure database $24k (2022)
HIV spending on governance and sustainability Financing USD 8 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $893k (2024)
HIV spending on prevention Financing USD 8 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $1.9m (2024)
HIV spending on prevention of vertical transmission Financing USD 8 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $110k (2024)
HIV spending on programmes for children and adolescents Financing USD 2 2016–2017 UNAIDS Global AIDS Monitoring expenditure database $437k (2017)
HIV spending on treatment, care and support Financing USD 8 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $2.4m (2024)
International HIV expenditure (country-reported) Financing USD 15 2016–2024 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $2.6m (2024)
Other bilateral HIV expenditure (country-reported) Financing USD 6 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $139k (2024)
Out-of-pocket HIV expenditure by households Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $283k (2017)
Private HIV and STD spending, national health accounts Financing USD 10 2014–2023 WHO Global Health Expenditure Database $1.8m (2023)
Private HIV expenditure (country-reported) Financing USD 2 2017 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $292k (2017)
US HIV disbursements managed by USAID Financing USD 6 2003–2014 ForeignAssistance.gov $6k (2014)
US HIV disbursements managed by other US agencies Financing USD 1 2014 ForeignAssistance.gov $509 (2014)
USAID funding received by the national TB programme Financing USD 2 2017–2018 WHO Global Tuberculosis Programme $0 (2018)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 23 2013–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 48.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 67 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 55.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 29 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 66.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 19 2004–2024 UNAIDS AIDSinfo 66.7% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 3 2018–2024 UNAIDS AIDSinfo 20.1% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 12 2013–2024 UNAIDS AIDSinfo 3.7% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 10 2013–2024 UNAIDS AIDSinfo 33.8% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 11 2015–2025 WHO Global Health Observatory 88.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 33 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.3% (2024)
HIV tests performed at a health facility Treatment cascade count 6 2018–2024 WHO HIV testing services dashboard 215,272 (2024)
HIV tests performed with the result returned to the person Treatment cascade count 37 2017–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 215,272 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 14 2011–2024 UNAIDS AIDSinfo 78.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 10 2015–2024 Global Fund Data Service, WHO Global Tuberculosis Programme 28 (2024)
Key-population people tested for HIV (count over the period) Treatment cascade count 34 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 1 2024 UNAIDS AIDSinfo 43.0% (2024)
Notified HIV cases, national case surveillance Treatment cascade count 11 2015–2025 National Centre for Infectious Diseases of Armenia, HIV situation analysis 2025 514 (2025)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 77 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme 4,257 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 84.0% (2025)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 1 2025 Global Fund Data Service 761 (2025)
People newly enrolled on ART during the year Treatment cascade count 12 2013–2024 WHO Global Tuberculosis Programme 541 (2024)
People tested for HIV in the last 12 months who received the result (household survey) Treatment cascade percent 48 2010–2016 Demographic and Health Surveys By population group, sex or age only, to 2016
Pregnant women tested for HIV in antenatal care Treatment cascade percent 6 2015–2021 UNAIDS AIDSinfo 98.0% (2021)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 42 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 28 (2024)
TB patients with an HIV test result recorded Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 369 (2024)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 200 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 13 (2024)
HIV prevalence among a key population Epidemic estimates percent 5 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.4% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 42 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 620 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 7,800 (2025)
Condom use at last higher-risk sex (household survey) Prevention and outreach percent 24 2000–2016 Demographic and Health Surveys By population group, sex or age only, to 2016
Key-population members reached by prevention programmes Prevention and outreach percent 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period) Prevention and outreach count 34 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 3 2022–2024 UNAIDS AIDSinfo 546,175 (2024)
People receiving PrEP Prevention and outreach count 4 2022–2025 Global Fund Data Service, UNAIDS AIDSinfo 152 (2025)
People with comprehensive correct knowledge of HIV (household survey) Prevention and outreach percent 52 2005–2016 Demographic and Health Surveys By population group, sex or age only, to 2016
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 100 (2025)
Estimated size of a key population Population denominators count 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 3,086,700 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 14.3% (2025)

Every row shown on the Armenia page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.